Loading company…
MSInsight develops genomic diagnostics for precision oncology.
Founded in 2022 in Boulogne-Billancourt, France, MSInsight develops MSIcare, a diagnostic tool using next-generation sequencing to detect microsatellite instability in solid tumors and liquid biopsies. It serves healthcare providers and research institutions. In March 2025, it raised EUR 1.6 million from Bpifrance Investissement, Calyseed, Capital Cell Investors, France Angels and Yes Securities for development and clinical validation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in